Evaluation of herbal formulation in contact dermatitis
- Conditions
- Health Condition 1: L259- Unspecified contact dermatitis, unspecified cause
- Registration Number
- CTRI/2023/07/055420
- Lead Sponsor
- Plant Ayu Life Sciences LLP Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Age from 18 - 60 yrs
2.Mild to moderate SCORing Atopic Dermatitis (SCORAD) > 5 % for > 1 months
3.Body surface involvement (BSI) of > 5%
4.Male or female
5.Willing to provide voluntary written informed consent.
1)Pregnant women and lactating mothers.
2)Patients suffering from systemic disorders as Cardiac, renal and hepatic diseases, Uncontrolled Diabetes mellitus, Uncontrolled Hypertension, Paralysis, Malignancy, Human immune deficiency virus infection, HBsAg, Leprosy.
3)Patients suffering from Psoriatic arthritis.
4)Patients who have received systemic therapy for psoriasis or those who have been treated with immunosuppressive immune - modulating treatment in previous 8 weeks.
5)Patient with personal or family history of malignant or premalignant skin tumours.
6)Subject with active infection either acute or chronic by fungi, viruses bacteria and parasites
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome of the study is to evaluate the changes in SCORing Atopic Dermatitis (SCORAD)Timepoint: baseline to 60 days
- Secondary Outcome Measures
Name Time Method The Secondary outcome of the study is to evaluate the changes in Dermatology Life Quality Index(DLQI)Timepoint: baseline to 60 days